SCM
NVO

Shelton Capital Management’s Novo Nordisk NVO Stock Holding History

Shelton Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,790
Closed -$262K – 752
2025
Q2 		$262K Hold
3,790
– – 0.01% 543
2025
Q1 		$263K Buy
+3,790
New +$313K 0.01% 538
2016
Q4 		– Sell
-70,856
Closed -$1.47M – 890
2016
Q3 		$1.47M Buy
+70,856
New +$1.76M 0.12% 158

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Shelton Capital Management's NVO Position: Q3 2025 in Review

Shelton Capital Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,790 shares — an estimated $262K sold.

Shelton Capital Management first reported a position in NVO in Q3 2016 and held it in 3 quarters. The position peaked at $1.47M in Q3 2016. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Shelton Capital Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Shelton Capital Management sold 3,790 Novo Nordisk shares in Q3 2025, an estimated $262K.
  • Shelton Capital Management first reported a position in Novo Nordisk in Q3 2016 and held it in 3 quarters.
  • Shelton Capital Management's Novo Nordisk position peaked at $1.47M in Q3 2016.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Shelton Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.